Alivira Animal Health (Alivira), a wholly owned subsidiary of SeQuent Scientific (SeQuent) has received three product registrations in Ukraine. The products have already been shipped to Ukraine and will be launched shortly. Ukraine is the largest egg and poultry market in Europe growing at over 8% year on year largely on account of expanding exports to European Union, Middle East, and Asia.
Alivira entered Ukraine in October 2016 and has since developed and initiated registration of a strong portfolio of nutrition products which bode well with the market’s transition from traditional antibiotics towards nutrition. Ukraine would make a significant contribution to Alivira’s growth as another six products are under registration.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
